Neurovascular device company Imperative Care (Campbell, Calif.) said today that it has completed the initial closing of an $85 million Series C financing round to support the commercial launch of its portfolio. The round was co-led by new investors Ally Bridge Group and Bain Capital Life Sciences. Existing investors Ascension Ventures, Delos Capital, Rock Springs […]
Ally Bridge Group
Venclose closes $27m Series C
Venous reflux disease treatment developer Venclose announced that it closed a Series C funding round totaling $27 million. Venclose develops the next-generation Venclose RF ablation system designed to close damaged veins and restore healthy blood flow in patients with venous reflux disease. The San Jose, Calif.–based company said that, after securing the $27 million, it […]
5 medtech stories we missed this week: Jan. 26, 2018
From Attune Medical receiving FDA 510(k) clearance to Synapse Medical having CE Mark approval, here are 5 medtech stories we missed this week but thought were still worth mentioning. 1. Attune Medical gets FDA 510(k) clearance Attune Medical announced in a Jan. 8 press release that it has received FDA 510(k) clearance for its EnsoETM […]